ReviewNeurobiology of disease2026
The extracellular matrix as a dynamic regulator of brain function and plasticity.
Review in Neurobiology of disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hypothalamic neurovascular and extracellular matrix remodeling: Cellular niche orchestration of immune-metabolic adaptation to nutritional stress.Reviews in endocrine & metabolic disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The brain extracellular matrix (ECM) is a dynamic and complex scaffold that not only provides structural support but also plays a key role in regulating synaptic plasticity, axonal regeneration, and cell signaling throughout development and into adulthood. This review focuses on the major components of the brain ECM-including structural proteins (e.g., collagen, elastin), adhesion glycoproteins (e.g., laminin, fibronectin, tenascin), and proteoglycans (e.g., aggrecan, brevican), with an emphasis on their region-specific expression patterns and dynamic changes during development and disease. We explore the role of the ECM in neurodegenerative diseases, psychiatric disorders, and chronic pain, and examine its interactions with glial cells (particularly astrocytes and microglia), which actively remodel the ECM through secretion of matrix-degrading enzymes such as matrix metalloproteinases (MMPs). This review also explores the unique challenges of studying the brain ECM, including its specialized composition and the technical limitations of existing methods. We discuss how recent advances in imaging, mass spectrometry, and omics technologies may provide new insights into ECM dynamics. Finally, we consider future directions, highlighting the potential of AI-based modeling and multi-omics integration to reveal the role of the ECM in brain function and dysfunction and inform a novel therapeutic strategy for neurological and psychiatric diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.